Federal AI Intelligence
Menu
Snapshot · OMB 2025 inventory · processed Oct 11, 2026
VA · VA-24-1684 · record R2240

Computer Aided Detection (CADe) of Neoplasia during Colonoscopy - “GI Genius”

Department of Veterans Affairs · VHA: Veterans Health Administration

Overview

Development stage
DeployedSource: c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
High-impact designation
High-impactSource: a) High-impact
Impact justification
Not reported
Start date
Not reported
Withheld from public reporting
Not reported

Mission

Topic area
Health and Medical
Operational functions
No function tag matched Derived by keyword rules; see methodology

Problem the AI is intended to solve

The device improves endoscopy quality by aiding neoplastic lesion detection during procedures. Multiple studies and meta-analyses have found these devices increase adenoma detection rates (ADR), a well-established metric for colonoscopy quality that is related to colon cancer incidence and death. Randomized implementation of the devices across VHA facilities allowed for a pragmatic evaluation of the impact of these devices on ADR. The evaluation demonstrated that the provision of colonoscopy Computer Aided Detection devices resulted in a statistically significant 21% increase in the odds of adenoma detection and an absolute increase in ADR of approximately 4% compared to colonoscopy without CADe.

Expected benefits

These devices demonstrably improve endoscopy quality within the VHA, which in turn improves outcomes for Veterans, ultimately reducing morbidity and mortality. Multiple studies and meta-analyses have found these devices increase adenoma detection rates (ADR), a well-established metric for colonoscopy quality that is related to colon cancer incidence and death. Randomized implementation of the devices across VHA facilities allowed for a pragmatic evaluation of the impact of these devices on ADR. The evaluation demonstrated that the provision of colonoscopy Computer Aided Detection devices resulted in a statistically significant 21% increase in the odds of adenoma detection and an absolute increase in ADR of approximately 4% compared to colonoscopy without CADe.

System outputs

During endoscopy, the CADe device automatically detects, and highlights suspected neoplastic lesions / polyps in real time. A highlighted rectangle automatically surrounds suspected lesions. No results or data are tracked or automatically documented. The device physically connects to existing endoscopes, video processors, and display monitors, but does not connect to the VA network.

Technology

AI classification
Computer visionSource: Computer Vision: AI that processes and interprets visual data (e.g., images and videos).
System name(s)
Not reported
Custom-developed code
No
Public source code
www.medtronic.com ↗

Sourcing

How it was built
Purchased from vendorSource: a) Purchased from a vendor
Vendor (as reported)
Not reported
Vendors (standardized)
None on the standard list

A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.

Data and privacy

Involves PII
Not reported
Privacy Impact Assessment
Not reported
Authorization to Operate
Not reported
Demographic features
Not reported
Training and evaluation data
Not reported
Federal Data Catalog
Not reported

Governance

0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.

Pre-deployment testingNo answer reported
AI impact assessmentNo answer reported
Independent reviewNo answer reported
Ongoing monitoringNo answer reported
Operator trainingNo answer reported
Fail-safeNo answer reported
Appeal processNo answer reported
User and public consultationNo answer reported

Potential impacts and how they were identified

Not reported